Cardiovascular effects of BRAF and MEK inhibitors in patients with melanoma: a prospective study incorporating risk scores, cardiac biomarkers and cardiovascular magnetic resonance imaging
Event:
ESC Congress 2024
Topic:
Cardio-Oncology
Session:
Cardiovascular complications in cardio-oncology: risk assessment
Cardiotoxicity of BRAF and MEK inhibitors in patients with melanoma: a real-world longitudinal study incorporating contemporary definitions and risk scores
Event:
Heart Failure 2023
Topic:
Cardio-Oncology
Session:
Cardiovascular disease in special poopulations - cardio-oncology